Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 14 X posts from 9 X users, with an upper bound of 31,111 followers.

RT @sitcancer: New #JITC: Immune-related response assessment during PD-1 inhibitor therapy in advanced #NSCLC patients https://t.co/V7wXvAX…

RT @sitcancer: New #JITC: Immune-related response assessment during PD-1 inhibitor therapy in advanced #NSCLC patients https://t.co/V7wXvAX…

New #JITC: Immune-related response assessment during PD-1 inhibitor therapy in advanced #NSCLC patients https://t.co/V7wXvAXjbX #LungCancer

RT @PDRennert: Varied response of metastatic lesions across organs in #nivolumab treated NSCLC pts https://t.co/f1jbuidec3 go mouse model…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.